Study of the RESS Process for the Micronization of Ethenzamide, Carbimazole and Menadione

碩士 === 國立臺灣大學 === 化學工程學研究所 === 105 === In this study, the rapid expansion of supercritical solution (RESS) process was applied to produce micronized particles of two active pharmaceutical ingredients (APIs) and one kind of food additives. They were ethenzamide, carbimazole and menadione, respectivel...

Full description

Bibliographic Details
Main Authors: Chun-Lin Wu, 吳俊霖
Other Authors: Yan-Ping Chen
Format: Others
Language:zh-TW
Published: 2017
Online Access:http://ndltd.ncl.edu.tw/handle/ucd5g9
id ndltd-TW-105NTU05063047
record_format oai_dc
spelling ndltd-TW-105NTU050630472019-05-15T23:39:38Z http://ndltd.ncl.edu.tw/handle/ucd5g9 Study of the RESS Process for the Micronization of Ethenzamide, Carbimazole and Menadione 利用超臨界溶液快速膨脹法進行藥物鄰乙氧基苯甲醯胺、甲亢平與甲萘醌之微粒化研究 Chun-Lin Wu 吳俊霖 碩士 國立臺灣大學 化學工程學研究所 105 In this study, the rapid expansion of supercritical solution (RESS) process was applied to produce micronized particles of two active pharmaceutical ingredients (APIs) and one kind of food additives. They were ethenzamide, carbimazole and menadione, respectively. The solubility of APIs and food additives is usually insoluble and poorly bioavailable. Therefore, by the reduction of targeted drug particles into submicron scale, it leads to a significant increase in dissolution rate and bioavailability. For ethenzamide, the micronized result was not found obviously under the operating condition (Text at 338 K, Pext at 200 bar, Tpost at 298 K and nozzle diameter at 1000 μm). The mean particle size was only reduced from 17.69 μm to 9.37 μm after the RESS process. However, in the dissolution rate test, the dissolution rate constant (kw) was increased from 0.0254 min-1 to 0.2471 min-1. The rate of dissolution was significantly enhanced by 9.73 times. Besides, the thermal and spectrometric properties of the ethenzamide were nearly consistent between the original and RESS processed particles. For carbimazole, the mean particle size was reduced from 84.58 μm to 3.63 μm under the operating condition (Text at 348 K, Pext at 220 bar, Tpost at 298 K and nozzle diameter at 1000 μm). The micronized degree was up to 23.3 times. The chemical properties of carbimazole were same. However, the melting point and the enthalpy of fusion were decreased because of the lower crystallinity after the RESS process. In addition, the dissolution rate constant (kw) of original and RESS processed particles was 0.1263 min-1 and 1.8957 min-1. Although the original dissolution rate of carbimazole was decent enough, the dissolution rate still improved 15.01 times after the RESS process. For menadione, the factorial design was applied as the design of experiment. It was for the purpose of discussing the effect of the different parameters on the value of micronized mean particle size. Three parameters, extraction temperature (Text), extraction pressure (Pext) and post-expansion temperature (Tpost), were chosen in this 23 factorial design. After finishing the 23 factorial design, nozzle diameter (DN) was selected as another parameter to discuss. Results from the analysis of variance (ANOVA) showed that post-expansion temperature was the most significantly parameter whose contribution was high to 91.086%. Then, the product in the most moderate condition (Run 4) was subsequently selected to be analyzed. The mean particle size was dramatically micronized from 129.14 μm to 1.17 μm. In qualitative analysis, there was no change of the physical and chemical properties after the RESS process. Moreover, the RESS processed menadione was closed to amorphous form because of its quite small intensity of crystallinity. In the dissolution rate test, the dissolution rate constant (kw) was changed from 0.0144 min-1 to 0.0631 min-1. As a result, the dissolution rate enhanced 4.38 times. Yan-Ping Chen 陳延平 2017 學位論文 ; thesis 104 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 國立臺灣大學 === 化學工程學研究所 === 105 === In this study, the rapid expansion of supercritical solution (RESS) process was applied to produce micronized particles of two active pharmaceutical ingredients (APIs) and one kind of food additives. They were ethenzamide, carbimazole and menadione, respectively. The solubility of APIs and food additives is usually insoluble and poorly bioavailable. Therefore, by the reduction of targeted drug particles into submicron scale, it leads to a significant increase in dissolution rate and bioavailability. For ethenzamide, the micronized result was not found obviously under the operating condition (Text at 338 K, Pext at 200 bar, Tpost at 298 K and nozzle diameter at 1000 μm). The mean particle size was only reduced from 17.69 μm to 9.37 μm after the RESS process. However, in the dissolution rate test, the dissolution rate constant (kw) was increased from 0.0254 min-1 to 0.2471 min-1. The rate of dissolution was significantly enhanced by 9.73 times. Besides, the thermal and spectrometric properties of the ethenzamide were nearly consistent between the original and RESS processed particles. For carbimazole, the mean particle size was reduced from 84.58 μm to 3.63 μm under the operating condition (Text at 348 K, Pext at 220 bar, Tpost at 298 K and nozzle diameter at 1000 μm). The micronized degree was up to 23.3 times. The chemical properties of carbimazole were same. However, the melting point and the enthalpy of fusion were decreased because of the lower crystallinity after the RESS process. In addition, the dissolution rate constant (kw) of original and RESS processed particles was 0.1263 min-1 and 1.8957 min-1. Although the original dissolution rate of carbimazole was decent enough, the dissolution rate still improved 15.01 times after the RESS process. For menadione, the factorial design was applied as the design of experiment. It was for the purpose of discussing the effect of the different parameters on the value of micronized mean particle size. Three parameters, extraction temperature (Text), extraction pressure (Pext) and post-expansion temperature (Tpost), were chosen in this 23 factorial design. After finishing the 23 factorial design, nozzle diameter (DN) was selected as another parameter to discuss. Results from the analysis of variance (ANOVA) showed that post-expansion temperature was the most significantly parameter whose contribution was high to 91.086%. Then, the product in the most moderate condition (Run 4) was subsequently selected to be analyzed. The mean particle size was dramatically micronized from 129.14 μm to 1.17 μm. In qualitative analysis, there was no change of the physical and chemical properties after the RESS process. Moreover, the RESS processed menadione was closed to amorphous form because of its quite small intensity of crystallinity. In the dissolution rate test, the dissolution rate constant (kw) was changed from 0.0144 min-1 to 0.0631 min-1. As a result, the dissolution rate enhanced 4.38 times.
author2 Yan-Ping Chen
author_facet Yan-Ping Chen
Chun-Lin Wu
吳俊霖
author Chun-Lin Wu
吳俊霖
spellingShingle Chun-Lin Wu
吳俊霖
Study of the RESS Process for the Micronization of Ethenzamide, Carbimazole and Menadione
author_sort Chun-Lin Wu
title Study of the RESS Process for the Micronization of Ethenzamide, Carbimazole and Menadione
title_short Study of the RESS Process for the Micronization of Ethenzamide, Carbimazole and Menadione
title_full Study of the RESS Process for the Micronization of Ethenzamide, Carbimazole and Menadione
title_fullStr Study of the RESS Process for the Micronization of Ethenzamide, Carbimazole and Menadione
title_full_unstemmed Study of the RESS Process for the Micronization of Ethenzamide, Carbimazole and Menadione
title_sort study of the ress process for the micronization of ethenzamide, carbimazole and menadione
publishDate 2017
url http://ndltd.ncl.edu.tw/handle/ucd5g9
work_keys_str_mv AT chunlinwu studyoftheressprocessforthemicronizationofethenzamidecarbimazoleandmenadione
AT wújùnlín studyoftheressprocessforthemicronizationofethenzamidecarbimazoleandmenadione
AT chunlinwu lìyòngchāolínjièróngyèkuàisùpéngzhàngfǎjìnxíngyàowùlínyǐyǎngjīběnjiǎxīànjiǎkàngpíngyǔjiǎnàikūnzhīwēilìhuàyánjiū
AT wújùnlín lìyòngchāolínjièróngyèkuàisùpéngzhàngfǎjìnxíngyàowùlínyǐyǎngjīběnjiǎxīànjiǎkàngpíngyǔjiǎnàikūnzhīwēilìhuàyánjiū
_version_ 1719151432946417664